Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial.

BMC Pulm Med · 2012 · PMC3502550 · PMID 23078148

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Overall, a lower percentage of patients on combination therapy experienced any asthma exacerbation (20.0%) compared to those administered the monotherapies (23.9% on fluticasone; 28.4% on formoterol) or placebo (32.4%), although the differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.